placebo pill

Preclinical

placebo pill is one of 50 therapeutic programs targeting Orthostatic; Hypotension, Neurogenic. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Orthostatic; Hypotension, NeurogenicRecruiting

Spinal Cord InjuryNot yet recruiting

Orthostatic; Hypotension, NeurogenicPreclinical

Recruiting

Spinal Cord InjuryPreclinical

Not yet recruiting

Competition

Competitive Landscape

65 competitors in Spinal Cord Injury

#DrugCompanyPhaseTrials

Zometa

Pfizer

Approved

5 2

Keppra

UCB

Approved

1 3

Cialis

Eli Lilly

Approved

1 4

Levitra

Bayer

Approved

1 5

Lioresal

Novartis

Approved

—6

Lyrica

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

4 7

Xarelto

WWim Janssens

Approved

1 8

Botox

RRevance Therapeutics, Inc.

Approved

1 9

Raldesy

Spiriva

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Orthostatic; Hypotension, Neurogenic

NCT04782830

Q1 2032

PreclinicalNot yet recruiting

Spinal Cord Injury

NCT07742553

Clinical

Trials by Indication[1]

Orthostatic Hypotension1 trial

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Completed·VVanderbilt University Medical Center·Phase 1·NCT04620382·31 enrolled

Spinal Cord Injury1 trial

A Multisite, Double-blind, Randomized Controlled Trial Comparing Body Composition, Muscle, and Bone Changes to TestosteRone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial

Not yet recruiting·VVA Office of Research and Development·Preclinical·NCT07742553·300 enrolled

Orthostatic; Hypotension, Neurogenic1 trial

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Recruiting·VVanderbilt University Medical Center·Preclinical·NCT04782830·29 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for placebo pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for placebo pill. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Vanderbilt University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: VVanderbilt University Medical Center

placebo pill

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q1 2032

Trials by Indication[1]

Orthostatic Hypotension1 trial

Spinal Cord Injury1 trial

Orthostatic; Hypotension, Neurogenic1 trial

References

Drug Info

Quick Facts

Related News